Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
08/06/1992 | WO1992012960A2 Derivatives of dicarboxylic acids having six to twelve carbon atoms and use of these derivatives and dicarboxylic acids alone in the preparation of pharmaceutical compositions for enteral and parenteral nutrition |
08/06/1992 | WO1992012734A1 Anti-growth factor antibodies in the treatment of vascular stenosis |
08/06/1992 | WO1992006954A3 Pyrrolidine dione derivatives |
08/05/1992 | EP0497516A1 Substituted pyrrolo-fused 6-membered heterocycles as angiotensin II antagonists |
08/05/1992 | EP0497300A1 Natural products with ten-ring lactone structure, method for their preparation and their use |
08/05/1992 | EP0497299A1 Decarestrictine and related compounds, process for their preparation and use |
08/05/1992 | EP0497201A1 Tricyclic compounds and intermediates thereof |
08/05/1992 | EP0497091A1 Bridged cyclic ketal derivatives |
08/05/1992 | EP0496852A1 Novel adenosine derivatives, their production and use |
08/04/1992 | US5136090 Biphenyl-5,5'-bis-alkanoic acid derivatives, their production and aldose reductase inhibitors containing the same |
08/04/1992 | US5135945 Cholesterol-lowering tocopherol analogs |
07/31/1992 | CA2060055A1 Substituted pyrrolo-fused 6-membered heterocycles as angiotensin ii antagonists |
07/30/1992 | DE4102244A1 14,16ss-ethano-15ss, 16(pfeil hoch)1(pfeil hoch)-cyclo-14ss-estra-1,3,5(10)-triene 14,16ss-ethano-15SS, 16 (arrow up) 1 (arrow up) cyclo-14ss-estra-1,3,5 (10) -trienes |
07/29/1992 | EP0496520A1 Novel bone acting agents |
07/29/1992 | EP0496479A1 NADH and NADPH as energy-substitutes |
07/29/1992 | EP0496173A1 Gall-nut extracts, their preparation and their uses |
07/29/1992 | EP0495963A1 Improved hypoglycemics |
07/29/1992 | CN1063041A Formulation and preparation process of thrombus dissolving agent for snake venom |
07/28/1992 | US5134164 Use of 3-guanidinopropionic acid in the treatment of excess adiposity |
07/28/1992 | US5134163 Retinoic acid for stretch marks |
07/28/1992 | US5134157 Trimethylcyclohexyl Pyroglutamate, Antilipemic Agents |
07/28/1992 | US5134156 Pharmaceutical composition and method for angiogenesis inhibition |
07/28/1992 | US5134155 Anticholesterol |
07/28/1992 | US5134139 1,5-benzothiazepine derivatives and preparation thereof |
07/28/1992 | US5133960 Use of tnf and lt for the preparation of drugs |
07/28/1992 | CA1305706C Benzoxazine derivatives and processes for preparation thereof |
07/28/1992 | CA1305668C Multivitamin preparation |
07/25/1992 | WO1992012711A1 Microbial oil mixtures and uses thereof |
07/24/1992 | WO1992012706A1 Method of reducing elevated blood sugar levels in humans |
07/23/1992 | WO1992012999A1 Novel insulin analogs |
07/23/1992 | WO1992012160A1 Bridged cyclic ketal derivatives |
07/23/1992 | WO1992012158A1 Cyclic ketal derivatives |
07/23/1992 | WO1992012156A1 Bridged cyclic ketal derivatives |
07/23/1992 | WO1992011869A1 Non-depleting cd4-specific monoclonal antibodies for the treatment of insulin-dependent diabetes mellitus (iddm) |
07/23/1992 | WO1992011838A1 Utilization of a growth factor in a slimming composition |
07/23/1992 | DE4101122A1 Kosmetisches oder pharmazeutisches mittel Cosmetic or pharmaceutical composition |
07/23/1992 | CA2100565A1 Insulin analogs |
07/23/1992 | CA2059751A1 Alep nut extracts, their preparation and their applications |
07/23/1992 | CA2059421A1 Bone acting agents |
07/22/1992 | EP0495349A2 Composition of an active agent for oral administration, especially to ruminants |
07/22/1992 | EP0495106A1 Osteogenesis promoter |
07/22/1992 | EP0495105A1 Inhibitor of absorption of digestion product of food and drink |
07/22/1992 | EP0495091A1 Aica riboside analogs |
07/22/1992 | EP0495050A1 Granulocyte-inhibiting polypeptide |
07/21/1992 | US5132324 Use of 3-guanidinopropionic acid in the treatment of non-insulin dependent diabetes mellitus (niddm) |
07/21/1992 | US5132317 Compounds |
07/21/1992 | US5132302 Use of aromatic aminoalkoxy derivatives for the treatment of troubles of the cerebrovascular system |
07/21/1992 | US5132113 Dietetics |
07/21/1992 | CA1305480C Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity |
07/21/1992 | CA1305422C Use of 2,5-anhydro-d-mannitol as a food intake modifier |
07/18/1992 | WO1992012979A1 2,4-DIOXO-PYRIDO [2,3-d]PYRIMIDINE-3-ACETIC ACIDS AND ESTERS AND SALTS THEREOF |
07/18/1992 | CA2100876A1 Anti-growth factor antibodies in the treatment of vascular stenosis |
07/18/1992 | CA2100164A1 2,4-dioxo-pyrido[2,3-d]pyrimidine-3-acetic acids and esters and salts thereof |
07/17/1992 | WO1992012702A1 Cosmetic or pharmaceutical preparation |
07/17/1992 | CA2099879A1 Cosmetic or pharmaceutical preparation |
07/15/1992 | EP0494777A1 (S)-11-Hydroxy-10-methyl aporphine and pharmaceutical compositions containing it |
07/15/1992 | EP0494622A1 Bridged cyclic ketal derivatives |
07/14/1992 | US5130317 Immunosuppressants and fibrosuppressants for metabolism of collagen |
07/14/1992 | US5130302 Boronated nucleoside, nucleotide and oligonucleotide compounds, compositions and methods for using same |
07/14/1992 | US5130301 Treatment of hypoxia, antiischemic disorders and metabolic disorders |
07/14/1992 | US5130245 Insert containing dna coding system; treatment of diseases causes by superoxide radicals |
07/14/1992 | CA1305166C 1-hydroxy-3-(n-methyl-n-proplylamino)propane-1,1- diphosphonic acid, pharmaceutical compositions and methods of use |
07/14/1992 | CA1305152C Oxazolidin-2-one derivatives as hypoglycemic agents |
07/14/1992 | CA1305059C Stabilized menadione bisulfite formulations and their preparation |
07/14/1992 | CA1305056C Method and compositions for reducing neurotoxic injury |
07/12/1992 | WO1992011853A1 Amino-substituted pyrimidines, derivatives and methods of use therefor |
07/12/1992 | CA2100351A1 Amino-substituted pyrimidines, derivatives and methods of use therefor |
07/12/1992 | CA2059142A1 11-hydroxyaporphines and their biologically active salt forms as 5-ht1a inhibitors |
07/11/1992 | WO1992011862A1 Hyperglycemic compositions |
07/10/1992 | WO1992012159A1 Bridged cyclic ketal derivatives |
07/10/1992 | CA2100257A1 Bridged cyclic ketal derivatives |
07/09/1992 | WO1992011365A1 Liver enriched transcription factor |
07/09/1992 | WO1992011269A1 Novel methylenebisphosphonic acid derivatives |
07/09/1992 | WO1992011267A1 Novel methylenebisphosphonic acid derivatives |
07/09/1992 | WO1992010996A1 Enhanced bioavailability pharmaceutical composition containing probucol |
07/08/1992 | EP0493782A2 Novel dihydropyridine amides, process for their preparation and drugs containing them |
07/08/1992 | EP0493380A1 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs. |
07/08/1992 | EP0202282B1 New use of 1,4-dihydropyridine derivatives |
07/08/1992 | CN1062534A Methylenebisphosphonic acid derivatives |
07/08/1992 | CN1062533A Methylenebisphosphonic acid derivatives |
07/08/1992 | CN1062532A Methylenebisphosphonic acid derivatives |
07/08/1992 | CN1062529A Indole derivatives |
07/07/1992 | US5128367 Osteoporosis |
07/07/1992 | US5128366 Pyrrole derivatives |
07/07/1992 | US5128347 Glycosidase inhibiting 1,4-dideoxy-4-fluoronojirimycin |
07/07/1992 | US5128331 Gen-diphosphonates |
07/07/1992 | US5128151 Stabilized menadione bisulfite formulations and their preparation |
07/07/1992 | US5128141 Otorhinolaryngological disorders |
07/07/1992 | US5128127 Immunization |
07/05/1992 | CA2058641A1 Dihydropyridine amides, processes for their preparation, and their use in medicaments |
07/01/1992 | EP0493151A1 Slimming composition containing ginkgo biloba as alpha-2 blocker |
07/01/1992 | EP0492667A1 1,4-Benzothiazine-2-acetic acid derivatives, processes for production thereof and their use |
07/01/1992 | EP0492474A1 1,3-Dioxolane derivatives as cholesterol-lowering agents |
07/01/1992 | EP0492318A2 Agistatins, metabolites from Fusarium sp., process for their preparation and their use |
07/01/1992 | EP0423318A4 Therapeutic cholesterol gallstone dissolution method |
07/01/1992 | CN1062350A Substituted pyridyl-dihydroxy-heptenoic acid and its salts |
07/01/1992 | CN1062293A Compositions containing psyllium |
07/01/1992 | CN1017242B New quianzoline derivatives and process for their production |
06/30/1992 | US5126356 Antiischemic agents |
06/30/1992 | US5126342 Imidazole angiotensin ii antagonists incorporating acidic functional groups |